Location
Areas of Expertise
About Me
Dimitra Skondra, MD, PhD, is a highly respected, board-certified retina specialist, with a particular focus on the medical and surgical treatment of vitreoretinal diseases. She in an expert in delivering care for diabetic eye disease, retinal detachment, age-related macular degeneration, retinal vein occlusions, eye trauma, proliferative vitreoretinopathy and intraocular infections, with advanced training and expertise in surgical repair of complex diabetic retinal detachments.
In addition to her clinical expertise, Dr. Skondra is an active researcher. As a physician-scientist, she is dedicated to investigating methods to improve treatment strategies for retinal conditions. Dr. Skondra is currently engaged in clinical and translational research in diabetes and other retinal diseases. Her research in retinal imaging aims to provide a better understanding of the pathogenesis, early detection and identification of prognostic information for to enable more targeted intervention and treatment.
Training
Vitreoretinal
2013Harvard Medical School
Fellowship
Ophthalmology
2011Weill Cornell Medicine
ResidencyPhD/Postdoctoral Research
2007Harvard Medical School
Masters / PhDPhD/Research
2004University of Crete Medical School
Masters / PhDBS, MD
2001University of Crete Medical School
Medical School
Awards & Honors
ISPB-Mentor
2016Compassionate Doctor Recognition
2015ISPB-Mentor
2014Retina Society Raymond Margherio Award
2013Harvard/Alcon Clinical Research Scholar Award
2013AUPO Resident Research Award
2011New York Academy of Medicine-Ophthalmology night
2010ARVO/Alcon Early Career Clinician Scientist Award
2006Knights Templar Eye Foundation Award
2006Tonseth-Joslin Fellowship Award
2005
Publications & Press
Fecal Microbial Profiles and Short-Chain Fatty Acid/Bile Acid Metabolomics in Patients With Age-Related Macular Degeneration: A Pilot Study.
Invest Ophthalmol Vis Sci. 2025 Apr 01; 66(4):21.•2025ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT.
Retina. 2024 02 01; 44(2):205-213.•2024FULL-THICKNESS MACULAR HOLE CLOSURE WITH TOPICAL MEDICAL THERAPY.
Retina. 2024 03 01; 44(3):392-399.•2024Glyburide confers neuroprotection against age-related macular degeneration (AMD).
Transl Res. 2024 Oct; 272:81-94.•2024INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES.
Retina. 2024 02 01; 44(2):197-204.•2024Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration.
Int J Mol Sci. 2024 Oct 22; 25(21).•2024Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.
JAMA Ophthalmol. 2024 Jan 01; 142(1):53-57.•2024Racial Differences in Choroidal Vascularity Index in Healthy Patients: Novel Insights.
Ophthalmic Surg Lasers Imaging Retina. 2024 Jan; 55(1):30-38.•2024Risk factors for severe retinopathy of prematurity stratified by birth weight and gestational age in privately insured infants.
J AAPOS. 2024 Dec; 28(6):104049.•2024The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy.
Invest Ophthalmol Vis Sci. 2024 Mar 05; 65(3):23.•2024
Certifications & Licensure
- Licensed In
- IL
- License Numbers
- 036.133705
